The GCC healthcare packaging market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 2.0 Billion |
Market Forecast in 2032
|
US$ 3.5 Billion |
Market Growth Rate 2024-2032 | 6.4% |
Healthcare packaging protects packaged medical devices and pharmaceutical products. It generally involves two types of packaging, namely primary and secondary packaging. The primary packaging has direct contact with the product like a bottle, cap, or label. It also safeguards the product from any chemical, climatic, biological, or mechanical hazards. On the other hand, secondary packaging is external to primary packaging and protects the healthcare product and the primary packaging. Healthcare packaging requires mandatory sterilization and is designed to uphold the highest medical guidelines and standards while preserving the integrity of the products.
The GCC healthcare packaging market is primarily driven by the growing population, increasing manufacturing output, and inflating incomes. Several manufacturing plants are being set up locally to create homegrown jobs in the region. Apart from this, the increasing prevalence of chronic diseases has resulted in extensive investments in the healthcare sector, which is providing a positive impact on the market. Additionally, research and development (R&D) activities have prompted manufacturers to develop flexible packaging that benefits the environment by saving energy during manufacturing while lowering the space utilization in landfills and minimizing emissions during the distribution process. The market is further being propelled by various initiatives by governments of several GCC countries for introducing cleaner and green packaging at low costs. Moreover, innovations such as the development of child-resistant and tamper-evident packaging are also bolstering the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC healthcare packaging market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on product, material, packaging, drug delivery mode and application.
Pharmaceuticals Packaging Market
Medical Device Packaging Market
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Billion |
Segment Coverage | Product, Material, Packaging, Drug Delivery Mode, Application, Country |
Countries Covered | Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The GCC healthcare packaging market was valued at US$ 2.0 Billion in 2023.
We expect the GCC healthcare packaging market to exhibit a CAGR of 6.4% during 2024-2032.
The growing adoption of healthcare packaging, as it assists in protecting pharmaceutical products and medical devices from chemical deterioration by preventing exposure to oxygen, moisture, light, and temperature fluctuations, is primarily driving the GCC healthcare packaging market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of healthcare packaging across several GCC nations, owing to the rising need for anesthetics, antibiotics, muscle relaxants, nutraceuticals, dietary supplements, etc., to combat the spread of the coronavirus infection.
Based on the product, the GCC pharmaceuticals packaging market can be divided into plastic bottles, caps and closures, blister packs, pre-fillable syringes, parenteral containers, pre-fillable inhalers, pouches, medication tubes, and others. Among these, plastic bottles exhibit clear dominance in the market.
Based on the material, the GCC pharmaceuticals packaging market has been bifurcated into plastics and polymers, paper and paperboard, glass, aluminum foil, and others. Currently, plastics and polymers account for the majority of the total market share.
Based on the packaging, the GCC pharmaceuticals packaging market can be segmented into primary packaging and secondary packaging, where primary packaging holds the largest market share.
Based on the drug delivery mode, the GCC pharmaceuticals packaging market has been divided into oral, injectable, dermal/topical, inhalable, and others. Among these, oral currently exhibits a clear dominance in the market.
Based on the product type, the GCC medical device packaging market can be categorized into trays, pouches, clamshell packs, and others. Currently, trays account for the majority of the total market share.
Based on the material, the GCC medical device packaging market has been segregated into plastic, paper, aluminium, tyvek, and others. Among these, plastic currently exhibits a clear dominance in the market.
Based on the application, the GCC medical device packaging market can be bifurcated into sterile packaging and non-sterile packaging. Currently, sterile packaging holds the largest market share.
On a regional level, the market has been classified into Saudi Arabia, UAE, Qatar, Oman, Kuwait, and Bahrain, where Saudi Arabia currently dominates the GCC healthcare packaging market.